NLK1 protein and NLK1 protein complexes
AssigneeCuraGen Corporation
InventorsKrishnan Nandabalan, Vincent P. Schulz, Meija Yang
Life of this patent
Estimating the term…
Loading patent…
AssigneeCuraGen Corporation
InventorsKrishnan Nandabalan, Vincent P. Schulz, Meija Yang
Estimating the term…
The present invention discloses complexes of the Nlk1 protein with proteins identified as interacting with the Nlk1 protein (Nlk1 protein-IPs) by a modified, improved yeast two hybrid assay system. The proteins which were identified to interact with the Nlk1 protein, and thus form complexes, included: TrkA, protein phosphatase 1α, 14-3-3ε, α-tropomyosin, vimentin, p0071, Ini-1, IP-1, IP-2, IP-3, IP-4 and IP-5, as well as derivatives, fragments analogs and homologs thereof. Methodologies of screening these aforementioned complexes for efficacy in treating and/or preventing various diseases and disorders, particularly, neoplasia, neurodegenerative disease, hypertrophic cardiomyopathy, viral infections and metabolic diseases and disorders are also disclosed herein.
A purified complex of a Nlk1 protein and Nlk1 protein-IP (interacting protein), wherein said Nlk1 protein-IP is selected from the group consisting of:
A chimeric protein comprising a fragment of an Nlk1 protein consisting of at least 6 amino acid residues fused, via a covalent bond to a fragment of Nlk1 protein-IP also consisting of at least 6 amino acid residues, wherein said Nlk1 protein-IP is selected from the group consisting of TrkA, protein phosphatase 1α, 14-3-3ε, α-tropomyosin, vimentin, p0071, Ini-1, IP-1 (SEQ ID NO:18), IP-2 (SEQ ID NO:20), IP-3 (SEQ ID NO:22), IP-4 ((SEQ ID NO:24) and IP-5 (SEQ ID NO:26), and wherein said fragment of the Nlk1 protein is a fragment that binds to the Nlk1 protein-IP and wherein said fragment of the Nlk1 protein-IP is a fragment capable of binding the Nlk1 protein.
A purified IP selected from the group consisting of IP-1 (SEQ ID NO:18), IP-2 (SEQ ID NO:20), IP-3 (SEQ ID NO:22), IP-4 (SEQ ID NO:24) and IP-5 (SEQ ID NO:26).
A purified protein encoded by a nucleic acid which is hybridizable under high stringent hybridization condition to the inverse complement of a DNA possessing a nucleotide sequence comprising at least 10 nucleotides of the nucleotide sequence selected from the group consisting of SEQ ID NO:17;
A purified fragment of a protein selected from the group consisting of:
A kit comprising a Nlk1 protein and aNlk1 protein-IP, wherein said Nlk1 protein-IP is selected from the group consisting of:
Dependencies are inferred from the claim text.